| 1 |
Qin P, Ran Y, Xie F, Liu Y, Wei C, Luan X, Wu J. Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer's disease. Bioorg Med Chem 2023;80:117178. [PMID: 36706609 DOI: 10.1016/j.bmc.2023.117178] [Reference Citation Analysis]
|
| 2 |
Aranha CMSQ, Reiner-Link D, Leitzbach LR, Lopes FB, Stark H, Fernandes JPS. Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H(3) and dopamine D(3) receptors. Bioorg Med Chem 2023;78:117132. [PMID: 36542960 DOI: 10.1016/j.bmc.2022.117132] [Reference Citation Analysis]
|
| 3 |
Madiha Kanwal, Sadia Sarwar, Humaira Nadeem, Athar Ata, Fawad A. Shah, Sumra Malik, Saima Maqsood, Ghulam A. Miana. New pyrazolone derivatives, synthesis, characterization, and neuroprotective effect against PTZ- induced neuroinflammation in mice. Iran J Basic Med Sci 2022;25. [PMID: 36544531 DOI: 10.22038/IJBMS.2022.62869.13912] [Reference Citation Analysis]
|
| 4 |
Zhang H, Peng Y, Zhuo L, Wang Y, Zeng G, Wang S, Long L, Li X, Wang Z. Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy. Eur J Med Chem 2022;242:114695. [PMID: 36044812 DOI: 10.1016/j.ejmech.2022.114695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Carocci A, Barbarossa A, Leuci R, Carrieri A, Brunetti L, Laghezza A, Catto M, Limongelli F, Chaves S, Tortorella P, Altomare CD, Santos MA, Loiodice F, Piemontese L. Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease. Antioxidants 2022;11:1631. [DOI: 10.3390/antiox11091631] [Reference Citation Analysis]
|
| 6 |
Vicente-zurdo D, Rosales-conrado N, León-gonzález ME, Brunetti L, Piemontese L, Pereira-santos AR, Cardoso SM, Madrid Y, Chaves S, Santos MA. Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease. Biomedicines 2022;10:1510. [DOI: 10.3390/biomedicines10071510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Rasras AJ, El-naggar M, Safwat NA, Al-qawasmeh RA. Cholyl 1,3,4-oxadiazole hybrid compounds: design, synthesis and antimicrobial assessment. Beilstein J Org Chem 2022;18:631-8. [DOI: 10.3762/bjoc.18.63] [Reference Citation Analysis]
|
| 8 |
Brunetti L, Leuci R, Carrieri A, Catto M, Occhineri S, Vinci G, Gambacorta L, Baltrukevich H, Chaves S, Laghezza A, Altomare CD, Tortorella P, Santos MA, Loiodice F, Piemontese L. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
